A DFG research unit is a close working alliance of several outstanding scientists who work together on a research task. In terms of its thematic, temporal and financial scope, the research project goes far beyond the funding options available under the normal or priority funding procedure. DFG funding for research groups is intended to help provide the necessary work force and material resources for close cooperation in the medium term - usually six years (from 01 October 2018: up to eight years).
(Lymph)angiogenesis and cellular immunity in inflammatory diseases of the eye
Speaker: Professor Dr. Claus Cursiefen; Centre for Ophthalmology, University Hospital Cologne
Novel molecular determinants for musculoskeletal extracellular matrix homeostasis - a systemic approach
Sprecher: Prof. Dr. Bent Brachvogel, Clinic and Polyclinic for Pediatrics and Adolescent Medicine
Established: in 2018
Clinical Research Units
In their various forms, research units can be integrated into overarching research policy initiatives: The German Research Foundation (DFG) funds and supports clinical research units with the aim of strengthening research networks in disease-oriented or patient-oriented (translational) clinical research and promoting the long-term implementation of scientific research units in clinical institutions.
In clinical research units , outstanding scientists can be supported in their medium-term, close teamwork on a particular research task, on which they gain results that cannot be achieved with the action of individual funding. Here you can find out more about the clinical research units at the Cologne Faculty of Medicine.
Exploiting defects in the DNA damage response for the treatment of chronic lymphocytic leukemia
Speaker: Professor Dr. Michael Hallek, Director of the Clinic I for Internal Medicine and CIO Köln Bonn
Established: in 2012
Molecular mechanisms of podocyte diseases - Nephrology on the way to precision medicine
Speaker: Professor Dr. Thomas Benzing, University Hospital Cologne Clinic II for Internal Medicine, Nephrology, Rheumatology, Diabetology and General Internal Medicine
The function of AdeRS and EsvA in the multidrug resistance of Acinetobacter baumannii
Partial project on: Adaptation and persistence of Acinetobacter baumannii, a pathogen of increasing importance
Applicant: Dr. Paul Higgins, Ph.D. University Hospital Cologne; Institute for Medical Microbiology, Immunology and Hygiene
Zelluläre Schutzmechanismen gegen mechanischen Stress
Sprecher: Professor Dr. Jörg Höhfeld, Fachgruppe Biologie, Institut für Zellbiologie
Laufzeit: seit 2018
Beteiligte Institutionen: Universität Freiburg, Universität Köln, Deutsche Sporthochschule Köln, Forschungszentrum Jülich, International Institute of Molecular and Cell Biology in Warschau (Polen)